EDAN INSTRUMENTS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.13 CNY | +0.33% |
|
-5.88% | -10.58% |
| Mar. 29 | Edan Instruments, Inc. Proposes Final Cash Dividend for the Year 2023 | CI |
| Mar. 28 | Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 1.74B 241M | Sales 2023 | 1.94B 268M | Capitalization | 5.92B 817M |
|---|---|---|---|---|---|
| Net income 2022 | 233M 32.16M | Net income 2023 | 221M 30.51M | EV / Sales 2022 | 3.46 x |
| Net cash position 2022 | 947M 131M | Net cash position 2023 | 924M 128M | EV / Sales 2023 | 2.58 x |
| P/E ratio 2022 |
29.9
x | P/E ratio 2023 |
26.7
x | Employees | 2,695 |
| Yield 2022 |
1.72% | Yield 2023 |
2.03% | Free-Float | 41.86% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.33% | ||
| 1 week | -5.88% | ||
| Current month | -16.39% | ||
| 1 month | -24.23% | ||
| 3 months | +5.31% | ||
| 6 months | -6.65% | ||
| Current year | -10.58% |
1 week
8.92
9.54
1 month
8.9212.07
Current year
7.1314.16
1 year
7.1316.77
3 years
7.1319.38
5 years
6.2027.90
10 years
4.9327.90
| Managers | Title | Age | Since |
|---|---|---|---|
Xi Cheng Xie
FOU | Founder | 59 | 95-08-01 |
Hao Zhang
CEO | Chief Executive Officer | 61 | 95-08-01 |
You Dong Zu
DFI | Director of Finance/CFO | 62 | 95-08-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chun Li
BRD | Director/Board Member | 67 | 10-03-25 |
Hao Zhang
CEO | Chief Executive Officer | 61 | 95-08-01 |
Yang Su
BRD | Director/Board Member | 56 | 10-03-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.63% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 9.13 | +0.33% | 7,432,390 |
| 24-04-19 | 9.1 | -0.55% | 7,208,500 |
| 24-04-18 | 9.15 | -2.35% | 8,994,256 |
| 24-04-17 | 9.37 | +3.88% | 10,578,500 |
| 24-04-16 | 9.02 | -7.01% | 12,103,850 |
End-of-day quote Shenzhen S.E., April 21, 2024
More quotes
Edan Instruments, Inc. is a China-based company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. The Company provides maternity product series, including doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors and maternity integrated diagnostic monitoring systems; electrocardiograph series, including digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, electrocardiographic workstations, single-channel electrocardiographs and multi-channel electrocardiographs; monitoring product series, including portable multi-variable monitors, central monitoring systems and oximeters, as well as ultrasonic image product series, including digital ultrasonic diagnostic systems and others. The Company is also involved in the spare parts sale and in vitro diagnostics products business.
Calendar
2024-04-25
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -10.58% | 731M | |
| +3.31% | 209B | |
| +2.05% | 175B | |
| +9.36% | 131B | |
| +17.66% | 99.98B | |
| -2.17% | 61.12B | |
| +14.05% | 52.34B | |
| -4.15% | 46.5B | |
| -3.68% | 39.24B | |
| +9.04% | 38.47B |
- Stock Market
- Equities
- 300206 Stock
